Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 GuidanceFeb 3, 2026 6:45 AM Eastern Standard Time# Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 GuidanceShare---- Advanced 11 Key Pivotal Study Starts in 2025 and ~20 Key Pivotal Study Starts Planned for 2026- Enters 2026 with Clear Strategic Priorities and Growing Late-Stage Pipeline- Focused Execution Drives Strong Full-Year 2025 EPS PerformanceNEW YORK--([BUSINESS WIRE])--Pfizer Inc. (NYSE: PFE) reported financial results fo ...